PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $411 | -100.0% | 14,895 | -77.7% | 0.00% | -100.0% |
| Q3 2020 | $1,308,000 | -12.3% | 66,928 | -20.7% | 0.00% | -33.3% |
| Q2 2020 | $1,491,000 | +957.4% | 84,417 | +322.1% | 0.00% | – |
| Q4 2019 | $141,000 | -26.6% | 20,000 | -30.1% | 0.00% | -100.0% |
| Q4 2018 | $192,000 | -79.7% | 28,602 | -68.9% | 0.00% | -50.0% |
| Q3 2018 | $947,000 | +69.1% | 92,041 | +10.4% | 0.00% | +100.0% |
| Q2 2018 | $560,000 | – | 83,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |